查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1555490

長效給藥技術和服務市場，按材料、劑型、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Long-Acting Drug Delivery Technologies and Services Market, By Material, By Dosage Form, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 386 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年長效給藥技術及服務市場規模為122.3423億美元，2024年至2032年複合年成長率為11.2%。

長效藥物傳輸技術與服務市場-市場動態

患者依從性的提高以及高血壓和精神疾病的盛行率預計將推動市場需求

糖尿病、高血壓、癌症和精神疾病越來越常見，通常需要長期治療。長效製劑可減少給藥頻率並提高患者依從性，預計將促進市場成長。人們越來越重視預防性醫療保健，包括使用長效藥物在病情惡化之前進行控制，從而提高生活品質並降低長期醫療費用。

生物製劑和生物相似藥長效製劑的開發正在擴大市場。這些藥物通常需要複雜的遞送系統才能隨著時間的推移保持穩定性和有效性。製藥技術的創新，例如奈米藥物傳輸系統、先進聚合物和改進的配方技術，使長效藥物傳輸系統更加有效和通用。更少的劑量和更少的給藥頻率帶來的更多便利鼓勵患者堅持他們的治療計劃，這可以帶來更好的健康結果並降低醫療成本。所有這些好處預計將有助於市場成長。

長效藥物傳輸技術與服務市場-關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 11.2% 左右的複合年成長率成長

根據材料細分，由於其長效藥物輸送效率高，預計聚合物細分市場將在 2023 年顯示最大的市場佔有率。

從劑型細分來看，長效注射劑由於其給藥效果較好且反應速度快，將成為 2023 年領先的劑型。

根據最終用戶細分，由於製藥和生物技術行業對藥品的高需求，製藥和生物技術公司細分市場將在 2023 年成為領先的最終用戶細分市場。

從地區來看，由於政府和 FDA 的支持，北美是 2023 年的主要收入來源。

長效藥物輸送技術與服務市場細分分析：

全球長效藥物傳輸技術和服務市場根據材料、劑型、最終用戶和地區進行細分。

市場依材料分為兩類：聚合物基和非聚合物基。基於聚合物的細分市場主導市場。聚合物藥物具有長效耐久性，因此在市場上越來越受歡迎。

根據劑型，市場分為四類：長效注射劑、作用植入劑、長效口服劑和其他。長效注射劑市場佔據主導地位。注射劑對常見的呼吸系統疾病具有很高的效率，這推動了細分市場的成長。

根據最終用戶，市場分為三類：製藥和生技公司、研發等。製藥和生物技術公司領域在市場中佔據主導地位，預計在預測期內將保持其高度主導地位。不斷成長的藥物開發和製藥技術正在推動市場需求。

長效給藥技術與服務市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。由於先進的醫療基礎設施、新技術的採用率以及大量的研發投資，美國在全球市場中佔有重要佔有率。歐洲是一個越來越重視個人化醫療和先進藥物輸送系統的主要市場。主要市場包括德國、法國和英國。拉丁美洲是一個新興市場，醫療保健服務範圍不斷擴大，醫療保健基礎設施投資不斷增加。

長效藥物輸送技術與服務市場-競爭格局：

長效給藥技術和服務市場的特徵是激烈的競爭和持續的創新。該領域的公司採取了各種策略，包括技術進步、夥伴關係、協作和市場擴張。公司正在投資奈米技術、可生物分解聚合物和先進的微球技術，以增強長效藥物傳輸系統。製藥公司、技術公司和學術機構之間的策略合作夥伴關係對於推動長效藥物傳輸技術和擴大市場範圍至關重要。

最新進展：

2023 年 2 月，EyePoint Pharmaceuticals 和 Rallybio 達成了一項研究協議，利用 Durasert(R) 技術評估 Rallybio 的補體成分 5 (C5) 抑制劑。

2023年4月，美國FDA核准了大塚開發的長效注射混懸液ABILIFY ASIMTUFII，每兩個月肌肉註一次，用於治療精神分裂症。

目錄

第1章：長效藥物傳輸技術與服務市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 長效藥物傳輸技術和服務市場片段（按材料）
    • 長效藥物傳遞技術與服務市場片段（按劑型）
    • 最終用戶的長效藥物傳輸技術和服務市場片段
    • 按國家/地區分類的長效藥物傳輸技術和服務市場片段
    • 按地區分類的長效藥物傳輸技術與服務市場片段
  • 競爭洞察

第 3 章：長效給藥技術與服務主要市場趨勢

  • 長效給藥技術與服務市場促進因素
    • 市場促進因素的影響分析
  • 長效給藥技術與服務市場限制
    • 市場限制影響分析
  • 長效給藥技術與服務市場機會
  • 長效給藥技術與服務市場未來趨勢

第 4 章：長效藥物傳遞技術與服務業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：長效藥物傳遞技術與服務市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：長效藥物傳輸技術與服務市場格局

  • 2023 年長效給藥技術與服務市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：長效藥物傳遞技術與服務市場 - 按材料

  • 概述
    • 按材料分類的細分市場佔有率分析
    • 聚合物基
    • 非聚合物基

第 8 章：長效藥物傳遞技術與服務市場 - 按劑型

  • 概述
    • 按劑型分類的細分市場佔有率分析
    • 長效注射劑
    • 長效植入式
    • 長效口服
    • 其他

第 9 章：長效藥物傳輸技術與服務市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 製藥和生物技術公司
    • 研究與開發
    • 其他

第 10 章：長效藥物傳輸技術與服務市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 長效給藥技術與服務北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按材料）
    • 北美市場規模與預測（按劑型）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 長效給藥技術與服務歐洲主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按材料）
    • 歐洲市場規模與預測（按劑型）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 長效給藥技術及服務亞太地區主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按材料）
    • 亞太地區市場規模與預測（按劑型）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 長效給藥技術與服務拉丁美洲主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按材料）
    • 拉丁美洲市場規模與預測（按劑型）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 長效給藥技術和服務中東和非洲主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按材料）
    • 中東和非洲市場規模及預測（按劑型）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 長效給藥技術與服務業

  • 競爭儀表板
  • 公司簡介
    • Pfizer Inc.
    • Roche Holding AG
    • Novartis International AG
    • Johnson & Johnson
    • Boehringer Ingelheim
    • Bristol-Myers Squibb
    • Viatris Inc.
    • ALZA Corporation
    • Eli Lilly and Company
    • Merck & Co., Inc.
    • Sanofi SA
    • AbbVie Inc.
    • Gilead Sciences, Inc.
    • GlaxoSmithKline plc
    • AstraZeneca plc
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV3639

REPORT HIGHLIGHT

Long-Acting Drug Delivery Technologies and Services Market size was valued at USD 12,234.23 Million in 2023, expanding at a CAGR of 11.2% from 2024 to 2032.

Long-Acting Drug Delivery Technologies and Services imply advanced methods and systems designed to administer medications over extended periods with fewer doses compared to traditional methods. These technologies aim to improve patient adherence, enhance therapeutic efficacy, and reduce the frequency of administration.

Long-Acting Drug Delivery Technologies and Services Market- Market Dynamics

Increasing patient adherence and the prevalence of hypertension, and psychiatric diseases are expected to propel market demand

Diabetes, hypertension, cancer, and psychiatric disorders are increasingly common and often require long-term management. Long-acting formulations reduce the frequency of dosing and improve patient adherence which is expected to bolster market growth. There is a growing emphasis on preventive healthcare, which includes using long-acting medications to manage conditions before they become severe, thereby improving quality of life and reducing long-term healthcare costs.

The development of long-acting formulations for biologics and biosimilars is expanding the market. These drugs often require complex delivery systems to maintain stability and effectiveness over time. Innovations in pharmaceutical technology, such as nano-based drug delivery systems, advanced polymers, and improved formulation techniques, are making long-acting drug delivery systems more effective and versatile. Enhanced convenience from fewer doses and less frequent administration encourages patients to stick to their treatment plans, which can lead to better health outcomes and reduced healthcare costs. All these benefits are projected to contribute to market growth.

Long-Acting Drug Delivery Technologies and Services Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.2% over the forecast period (2024-2032)

Based on Material segmentation, the polymer-based segment was predicted to show maximum market share in the year 2023, owing to its high efficiency in long-acting drug delivery.

Based on Dosage Form segmentation, long acting injectables segment was the leading Dosage Form in 2023, owing to its greater effects in drug delivery & quick response.

Based on End User segmentation, the pharmaceutical & biotech companies' segment was the leading End User segment in 2023, owing to the high demand for drugs in the pharma & biotech industries.

Based on region, North America was the leading revenue generator in 2023, due to the government & FDA support.

Long-Acting Drug Delivery Technologies and Services Market- Segmentation Analysis:

The Global Long-Acting Drug Delivery Technologies and Services Market is segmented based on Material, Dosage Form, End User, and Region.

The market is divided into two categories based on Material: polymer-based and non-polymer based. The polymer-based segment dominates the market. Polymer-based drugs provide long-acting durability and thus are gaining more traction in the market.

The market is divided into four categories based on Dosage Form: long acting injectables, acting implantables, long-acting oral, and others. The long acting injectables segment dominates the market. Injectables have high efficiency in common respiratory disorders which is fueling segment growth.

The market is divided into three categories based on End Users: pharmaceutical & biotech companies, research & development, and others. The pharmaceutical & biotech companies segment dominates the market and is expected to maintain its high dominance during the forecast period. The growing number of drug development and pharma technologies are boosting market demand.

Long-Acting Drug Delivery Technologies and Services Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. The United States holds a significant share of the global market due to advanced healthcare infrastructure, high adoption rates of new technologies, and substantial R&D investments. Europe is a major market with a growing emphasis on personalized medicine and advanced drug delivery systems. Key markets include Germany, France, and the UK. Latin America is an emerging market with expanding healthcare access and increasing investments in healthcare infrastructure.

Long-Acting Drug Delivery Technologies and Services Market- Competitive Landscape:

The long-acting drug delivery technologies and services market is characterized by significant competition and ongoing innovations. Companies in this space are engaged in various strategies, including technological advancements, partnerships, collaboration, and market expansions. Companies are investing in nanotechnology, biodegradable polymers, and advanced microsphere technologies to enhance long-acting drug delivery systems. Strategic partnerships between pharmaceutical companies, technology firms, and academic institutions are crucial for advancing long-acting drug delivery technologies and expanding market reach.

Recent Developments:

In February 2023, EyePoint Pharmaceuticals and Rallybio formed a research agreement to assess Rallybio's inhibitors of complement component 5 (C5) using Durasert(R) technology.

In April 2023, the U.S. FDA approved ABILIFY ASIMTUFII, a long-acting injectable suspension, developed by Otsuka, administered intramuscularly once every two months for the treatment of schizophrenia.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LONG-ACTING DRUG DELIVERY TECHNOLOGIES AND SERVICES MARKET KEY PLAYERS

  • Pfizer Inc.
  • Roche Holding AG
  • Novartis International AG
  • Johnson & Johnson
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Viatris Inc.
  • ALZA Corporation
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Sanofi S.A.
  • AbbVie Inc.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • AstraZeneca plc
  • Others

GLOBAL LONG-ACTING DRUG DELIVERY TECHNOLOGIES AND SERVICES MARKET, BY MATERIAL- MARKET ANALYSIS, 2019-2032

  • Polymer-based
  • Non-polymer Based

GLOBAL LONG-ACTING DRUG DELIVERY TECHNOLOGIES AND SERVICES MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019-2032

  • Long Acting Injectables
  • Long Acting Implantable
  • Long-acting Oral
  • Others

GLOBAL LONG-ACTING DRUG DELIVERY TECHNOLOGIES AND SERVICES MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Pharmaceutical & Biotech Companies
  • Research & Development
  • Others

GLOBAL LONG-ACTING DRUG DELIVERY TECHNOLOGIES AND SERVICES MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Long-Acting Drug Delivery Technologies and Services Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Long-Acting Drug Delivery Technologies and Services Market Snippet by Material
    • 2.1.2. Long-Acting Drug Delivery Technologies and Services Market Snippet by Dosage Form
    • 2.1.3. Long-Acting Drug Delivery Technologies and Services Market Snippet by End User
    • 2.1.4. Long-Acting Drug Delivery Technologies and Services Market Snippet by Country
    • 2.1.5. Long-Acting Drug Delivery Technologies and Services Market Snippet by Region
  • 2.2. Competitive Insights

3. Long-Acting Drug Delivery Technologies and Services Key Market Trends

  • 3.1. Long-Acting Drug Delivery Technologies and Services Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Long-Acting Drug Delivery Technologies and Services Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Long-Acting Drug Delivery Technologies and Services Market Opportunities
  • 3.4. Long-Acting Drug Delivery Technologies and Services Market Future Trends

4. Long-Acting Drug Delivery Technologies and Services Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Long-Acting Drug Delivery Technologies and Services Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Long-Acting Drug Delivery Technologies and Services Market Landscape

  • 6.1. Long-Acting Drug Delivery Technologies and Services Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Long-Acting Drug Delivery Technologies and Services Market - By Material

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Material, 2024 & 2032 (%)
    • 7.1.2. Polymer-based
    • 7.1.3. Non-polymer Based

8. Long-Acting Drug Delivery Technologies and Services Market - By Dosage Form

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Dosage Form, 2024 & 2032 (%)
    • 8.1.2. Long Acting Injectables
    • 8.1.3. Long Acting Implantable
    • 8.1.4. Long-acting Oral
    • 8.1.5. Others

9. Long-Acting Drug Delivery Technologies and Services Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Pharmaceutical & Biotech Companies
    • 9.1.3. Research & Development
    • 9.1.4. Others

10. Long-Acting Drug Delivery Technologies and Services Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Long-Acting Drug Delivery Technologies and Services Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Long-Acting Drug Delivery Technologies and Services Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Long-Acting Drug Delivery Technologies and Services Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Long-Acting Drug Delivery Technologies and Services Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Long-Acting Drug Delivery Technologies and Services Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Long-Acting Drug Delivery Technologies and Services Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer Inc.
    • 11.2.2. Roche Holding AG
    • 11.2.3. Novartis International AG
    • 11.2.4. Johnson & Johnson
    • 11.2.5. Boehringer Ingelheim
    • 11.2.6. Bristol-Myers Squibb
    • 11.2.7. Viatris Inc.
    • 11.2.8. ALZA Corporation
    • 11.2.9. Eli Lilly and Company
    • 11.2.10. Merck & Co., Inc.
    • 11.2.11. Sanofi S.A.
    • 11.2.12. AbbVie Inc.
    • 11.2.13. Gilead Sciences, Inc.
    • 11.2.14. GlaxoSmithKline plc
    • 11.2.15. AstraZeneca plc
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us